Advances in IgAN Care From Kidney Week
Jörg Latus, MD
Sydney Tang, MBBS, MD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, MD, PhD
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
Joel Topf, MD
James Burton, DM, FRCP
Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Why We Should Be PRO Patients With CKD-Associated Pruritus
Lucio Manenti, MD, PhD
Jeanette Finderup, PhD, MHR, RN
Sebastian Koball, MD
Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
PROTECT Study in IgAN: Topline Data
Jonathan Barratt, MD
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George Bakris
David Bushinsky, MD
Lars Lund, MD
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Can We Do Better in IgAN?
Annette Bruchfeld, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.